期刊文献+

延续性护理对多发性骨髓瘤化疗患者生活质量及相关并发症的影响

下载PDF
导出
摘要 目的观察延续性护理对多发性骨髓瘤化疗患者生活质量及相关并发症的影响。方法选择2020年10月—2022年9月在南京医科大学附属宿迁第一人民医院接受治疗的85例多发性骨髓瘤化疗患者,随机分为2组,观察组45例出院后予以延续性护理,对照组40例予以常规出院指导护理,随访6个月,比较2组疼痛改善情况、自我管理能力、并发症发生率及生活质量。结果观察组和对照组疼痛总缓解率分别为93.02%(40/43)、73.81%(31/42),观察组明显高于对照组(P<0.05)。护理后2组自我护理能力测定量表(ESCA)评分、癌症自我效能感量表(SUPPH)评分、健康促进生活方式量表-Ⅱ(HPLP-Ⅱ)评分及生活质量综合评定量表(GQOL-74)各维度评分均明显高于护理前(P均<0.05),且观察组均明显高于同期对照组(P均<0.05)。观察组和对照组相关并发症发生率分别为6.98%(3/43)、28.57%(12/42),观察组明显低于对照组(P<0.05)。结论延续性护理应用于多发性骨髓瘤化疗患者可缓解疼痛程度,提高患者化疗居家期间自我管理能力,以减少相关并发症,提高患者生活质量。
出处 《现代中西医结合杂志》 CAS 2024年第9期1289-1293,共5页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献12

二级参考文献85

  • 1麦玉洁,邱录贵,李睿,靳风艳,白洁,万长春,王建祥,季林祥,肖志坚,钱林生.432例多发性骨髓瘤临床分析[J].白血病.淋巴瘤,2004,13(4):198-201. 被引量:27
  • 2李燕郴,钟玉萍,陈世伦,王慧娟,胡影.多发性骨髓瘤147例临床分析[J].中华内科杂志,2007,46(9):765-766. 被引量:10
  • 3Anderson KC. New insights into therapeutic targets in myeloma [A]. Hematology Am Soc Hematol Educ Program, 2011:184-190. 被引量:1
  • 4Augustson BM, Begum G, Dunn]A, et al. Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002-Medica1 Research Council Adult Leukaemia Working Partym.] Clin Oncol, 2005, 23(36):9219-9226. 被引量:1
  • 5Beksac M, Haznedar R, Firatli- Tuglular T, et al. Addition of thalid- omide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group[J], Eur] Haematol, 2011, 86(1):16-22. 被引量:1
  • 6Blade], Rosinol L.Renal, hematologic and infectious complications in multiple myeloma[J]. Best Pract Res Clin Haematol, 2005, 18(4): 635-652. 被引量:1
  • 7Murakami H, Hayashi K, Hatsumi N, et al. Risk factors for early death in patients undergoing treatment for multiple myeloma[J], Ann Hematol, 2001, 80:452-455. 被引量:1
  • 8Drayson M, Begum G, Basu S, et al. Effects of paraprotein heavy and light chain types and free light chain load on survival in myeloma: an analysis of patients receiving conventional-dose chemotherapy in Medical Research Council UK multiple myeloma trials[J], Blood, 2006, 108(6):2013-2019. 被引量:1
  • 9Ludwig H, Hajek R, T6thov6 E, et al. Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma[J]. Blood, 2009,113(15):3435-3442. 被引量:1
  • 10McCloskey EV, MacLennan IC, Drayson MT, et al. A randomized trial of the effect of clodronate on skeletal morbidity in multiple myeloma:MRC Working Party on Leukaemia in Adults[J]. Br] Haernatol, 1998, 100(2) :317-325. 被引量:1

共引文献640

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部